Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
39
CLF Quote, Financials, Valuation and Earnings
Last price:
$9.68
Seasonality move
:
4.8%
Day range:
$10.10 - $10.47
52-week range:
$8.50 - $22.97
Dividend yield:
0%
P/E ratio:
175.97x
P/S ratio:
0.25x
P/B ratio:
0.75x
Volume:
16.4M
Avg. volume:
22.4M
1-year change:
-48.63%
Market cap:
$5B
Revenue:
$19.2B
EPS (TTM):
-$1.58
Cleveland-Cliffs Number of Institutional Trades
Cleveland-Cliffs Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$9.6B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$8.1B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Cleveland-Cliffs Institutional Ownership
-
What Percentage Of CLF Is Owned by Institutions?
-- of CLF is owned by institutions.
-
How Many Institutions Own CLF Shares?
Cleveland-Cliffs stock is owned by 1,202 institutional shareholders at this time.
-
Have Institutions Been Buying CLF Stock?
Yes, institutions have bought 493.7M shares of CLF in the last quarter.
-
Have Institutions Been Selling CLF Stock?
Yes, institutions have sold 396.5M shares of CLF over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
